Uniwersytecki Szpital Kliniczny W Opolu

Peripheral Vascular Disease

Clinical research at Uniwersytecki Szpital Kliniczny W Opolu includes studies in lower extremity artery disease, with attention to superficial femoral artery restenosis and the management of patients treated with vascular stents.

  • Restenosis prevention
  • Endovascular stent treatment
  • Colchicine
  • Paclitaxel-eluting stents

The sponsor’s vascular research focuses on outcomes relevant to arterial re-narrowing and treatment strategies in peripheral arterial disease.

Critical Care Metabolic Support

The hospital also supports research in intensive care, particularly among patients with severe vitamin D3 deficiency receiving continuous renal replacement therapy.

  • Critical illness
  • Renal replacement therapy
  • Enteral supplementation
  • 25(OH)D3

These studies address the correction of micronutrient deficiency in patients with complex organ support needs in the intensive care unit.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Comparison of Two Vitamin D3 Doses (500,000 IU vs 750,000 IU) in Critically Ill Patients with Vitamin D Deficiency Receiving Continuous Renal Replacement Therapy

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Poland
  • Study on Colchicine for Preventing Artery Narrowing in Patients with Lower Extremity Artery Disease

    Recruiting

    1 1 1 1
    Investigated drugs:
    Poland